WUXI BIO (02269) expects FY25 profit up 46.3% X

11/02/2026 10:35

(Infocast News) WUXI BIO (02269) issued a positive profit alert.

It is expected that the revenue of the Company for the total year ended December 31, 2025 will increase approximately 16.7% to RMB21,790 million; the gross profit margin rate will expand by approximately 5 percentage points to 46.0%; the adjusted gross profit will increase to approximately RMB10,638 million, representing an increase of approximately 25.5% year-on-year; the profit of the Company and the profit attributable to equity shareholders of the Company for the total year ended December 31, 2025 will increase approximately 45.3% to RMB5,733 million and approximately 46.3% to RMB4,908 million, respectively; and after adjusting for share-based compensation expenses, foreign exchange gain & loss, and gain & loss from equity investments, asset divestiture, restructuring and related one-time costs, the non-IFRS adjusted net profit of the Company will increase approximately 22.0% to RMB6,586 million, compared with that of last year.
(WL)

Infocast Limited and its information providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.